drugset

drugset / Trial / NCT01345799

A Study of TRK-170 for the Treatment of Crohn's Disease

NCT01345799 ↗

Phase 2 Completed 123 enrolled Toray Industries, Inc

RandomizedParallel-groupDouble-blindTreatment

Summary

In Crohn's Disease Patients * To evaluate the efficacy of TRK-170 * To evaluate the PK characteristics of TRK-170 * To assess the safety of TRK-170

Timeline

Start: 2011-04
Primary completion: —
Completion: 2014-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TRK-170	Unknown	—	—

Indications